Mead Johnson (MJN) Massachusetts Contract Loss May Lead to Much Biggter Texas Contract Win - BMO

October 6, 2016 8:37 AM EDT
Get Alerts MJN Hot Sheet
Price: $80.57 -0.38%

Rating Summary:
    8 Buy, 12 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 27 | New: 7
Trade MJN Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

BMO Capital analyst Amit Sharma weighed in on Mead Johnson Nutrition (NYSE: MJN) after the company lost the WIC infant formula contract in Massachusetts to Abbott, effective October 1.

Sharma notes the loss of Massachusetts, which accounts for 3% of Mead's US volumes, creates sales/margin pressure into 2017. However, they wonder whether Mead's decision to concede Massachusetts (and several other smaller WIC contracts over the past 12 months) is part of its strategy to bid aggressively for the much larger WIC contract in Texas (7-8x bigger than Massachusetts).

The firm estimates that the loss of this contract could have a $0.06-$0.08 impact on Mead's EPS. FY 2016 EPS was trimmed from $3.49 to $3.47 and FY 2017 EPS from $3.83 to $3.77.

The firm maintained an Outperform rating and trimmed its price target to $96.00 (from $97.00)

For an analyst ratings summary and ratings history on Mead Johnson Nutrition click here. For more ratings news on Mead Johnson Nutrition click here.

Shares of Mead Johnson Nutrition closed at $79.11 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

BMO Capital

Add Your Comment